Such evidence may include a) significance in another dimension of the study, b) inclusion in a common pathway with a highly significant compound, or c) residing in a similar functional biochemical family with other significant compounds.
← all excerpts
Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.
1
—
—